about
Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane ReviewLevetiracetam monotherapy for epilepsyManagement of Status Epilepticus in ChildrenThe antiepileptic drug levetiracetam suppresses non-convulsive seizure activity and reduces ischemic brain damage in rats subjected to permanent middle cerebral artery occlusionLevetiracetam induced urticarial vasculitis: a preliminary reportIdentification of the antiepileptic racetam binding site in the synaptic vesicle protein 2A by molecular dynamics and docking simulations.Results of phase 2 safety and feasibility study of treatment with levetiracetam for prevention of posttraumatic epilepsy.Prospects of levetiracetam as a neuroprotective drug against status epilepticus, traumatic brain injury, and strokeUpdate on neuropathic pain treatment: ion channel blockers and gabapentinoids.The adverse effects profile of levetiracetam in epilepsy: a more detailed look.Mechanisms of levetiracetam in the control of status epilepticus and epilepsy.Seizure management in patients with gliomas.Rhabdomyolysis induced by antiepileptic drugs: characteristics, treatment and prognosis.Efficacy and safety of prophylactic levetiracetam in supratentorial brain tumour surgery: a systematic review and meta-analysis.Treating epileptic emergencies - pharmacological advances.Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy.Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.Acute generalized exanthematous pustulosis induced by levetiracetam.Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex.Levetiracetam-Induced Skin Hyperpigmentation: An Extremely Rare Undesirable Side Effect.Neuroprotective, neuroplastic, and neurobehavioral effects of daily treatment with levetiracetam in experimental traumatic brain injury.Antiepileptic drugs: Impacts on human serum paraoxonase-1.Anticonvulsant Activity of Enantiomeric N-trans-Cinnamoyl Derivatives of 2-Aminopropan-1-ols and 2-Aminobutan-1-ols.
P2860
Q24200332-EA2F3233-A247-4859-B250-4E9C1162CEA8Q24201619-79DC151A-12D1-4EF8-9E59-56BD9D60D3C2Q26752721-B8235C80-F719-4D97-86A8-745B9ED07F62Q28535091-339E1C92-0536-4F0F-ADF4-DB6A93F5B0BAQ33919464-B0D91647-45F4-46B3-9073-699344F2FD3EQ35357221-629F7CC6-CB7B-410D-9818-C094E81F9566Q36703584-52A466C6-DE3A-4FCD-BE71-66BF0A9FEE72Q37276387-3495B084-842C-4297-BF20-C30148E0C6B2Q38124283-B09F749C-0FD7-46C6-A1DB-609259326DD0Q38164431-D9226203-4F11-4517-BD93-06B1342B8FA5Q38189350-AD3F2956-BD72-4747-AB35-AED7BF92082DQ38189495-40761C05-B972-49A8-8F88-641CA8B42093Q38691963-A4D24B05-B27F-4C43-878D-EAA61AB5440FQ38761893-2BA9ABA6-CCA2-4161-B773-3C5A263A8498Q38968069-405609F1-D7CB-4257-97AD-C4E55B7A52AAQ39206242-2C92C04D-A387-4F01-8C6C-9FC0F4318ED8Q43712982-157C01E6-125F-46C4-A77B-BC268F04AB22Q45340744-DD8D49B9-2210-4043-836E-E6840B0BD936Q47222228-EB39A92D-EFDE-4EA8-B18A-9E1DD149E517Q49216454-4D6260AB-9E06-447C-909C-C0608CDA0100Q50736416-438D7A2E-1231-4A12-B8D3-A318706770E7Q51229073-70888883-CA30-4C32-9A57-FAD00151EE18Q53112986-E0237937-00F6-4588-B5C8-C9B53B703CD6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Levetiracetam: a comprehensive review.
@en
Levetiracetam: a comprehensive review.
@nl
type
label
Levetiracetam: a comprehensive review.
@en
Levetiracetam: a comprehensive review.
@nl
prefLabel
Levetiracetam: a comprehensive review.
@en
Levetiracetam: a comprehensive review.
@nl
P2860
P356
P1476
Levetiracetam: a comprehensive review.
@en
P2093
Amy Z Crepeau
David M Treiman
P2860
P304
P356
10.1586/ERN.10.3
P577
2010-02-01T00:00:00Z